Can precision medicine overcome the limitations of traditional medicine?
Combining deep desk research with insights from industry experts, this report takes a 360-degree view into precision medicine, looking at its evolution, applications in life sciences and healthcare, legislations, policies and frameworks.
Can precision medicine overcome the limitations of traditional medicine?
Efficiency of Precision Medicine
FDA’s CDx Revolution
170
CDx have been approved by the FDA to date.
38%
patients on antidepressants were found to be ineffective in Conventional therapies
100% on asthma drugs
50% arthritis medicines
75% on cancer drugs
Innovations and cutting edge technologies like Quantum computers could vastly accelerate the analysis of pangenomes – new representations of DNA sequences that capture population diversity data, enabling more precise and individualized genetic insights.
Efficiency of Precision Medicine
FDA’s CDx Revolution
170
CDx have been approved by the FDA to date.
38%
patients on antidepressants were found to be ineffective in Conventional therapies
100% on asthma drugs
50% arthritis medicines
75% on cancer drugs
Innovations and cutting edge technologies like Quantum computers could vastly accelerate the analysis of pangenomes – new representations of DNA sequences that capture population diversity data, enabling more precise and individualized genetic insights.
To know more about our
Healthcare Research and Analytics Solutions
About Us
SGA offers end-to-end support for companies in precision medicine through a range of specialized services. We assist them in estimating expected product demand using quantitative and qualitative market research for HCPs, patients, and caregivers. SGA’s REAL forecast methodology further helps project future product potential for the next 5–10 years, complemented by dynamic dashboards for executive visualization. With our pricing benchmark analysis, we identify the overall/annual cost of therapy for competitors as well as analogs and support strategy for penetration in emerging and non-innovator-friendly markets.
Additionally, SGA’s supply chain research and analytics assist in identifying optimal vendors and streamlining logistics, ensuring efficient supply chain management.
About Us
SGA offers end-to-end support for companies in precision medicine through a range of specialized services. We assist them in estimating expected product demand using quantitative and qualitative market research for HCPs, patients, and caregivers. SGA’s REAL forecast methodology further helps project future product potential for the next 5–10 years, complemented by dynamic dashboards for executive visualization. With our pricing benchmark analysis, we identify the overall/annual cost of therapy for competitors as well as analogs and support strategy for penetration in emerging and non-innovator-friendly markets.
Additionally, SGA’s supply chain research and analytics assist in identifying optimal vendors and streamlining logistics, ensuring efficient supply chain management.
SGA offers automation-powered and decision-oriented research expertise required to succeed in this rapidly evolving market.
SGA offers automation-powered and decision-oriented research expertise required to succeed in this rapidly evolving market.
Our team is dedicated to building a robust Life Sciences and Healthcare practice, with a strong emphasis on insights and analytics to drive innovation and excellence.
Our team is dedicated to building a robust Life Sciences and Healthcare practice, with a strong emphasis on insights and analytics to drive innovation and excellence.
